LYME TESTING
TICKBORNE diseases are rising throughout the US from a variety of ticks, which carry and pass on different microorganisms to humans and animals. Tickborne disease have more than doubled in 13 years and represent 77% of all vector-borne disease reports. LYME DISEASE accounts for 82% of all cases.
ADVANCED TESTING allows:
- Earlier detection than standard lab tests to help patients recover quickly
- Unparalleled SENSITIVITY and SPECIFICITY. (First-of-its-kind SILICON MICROARRAY technology and CHEMILUMINESCENCE detection)
- Advanced LYME and CO-INFECTION detection. (Our technology tests ANTIBODIES (indirect) and DNA (direct) for the most comprehensive analysis.